News Archives - Biotherapy Partners https://biotherapypartners.com/category/news/ Commited to your success Thu, 14 Mar 2024 10:35:51 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://biotherapypartners.com/wp-content/uploads/2022/12/cropped-logo_site_mini-32x32.png News Archives - Biotherapy Partners https://biotherapypartners.com/category/news/ 32 32 Biotherapy Partners will attend SFTCG worshop “gene editing and cell therapy” https://biotherapypartners.com/biotherapy-partners-will-attend-sftcg-worshop-gene-editing-and-cell-therapy/ https://biotherapypartners.com/biotherapy-partners-will-attend-sftcg-worshop-gene-editing-and-cell-therapy/#respond Tue, 12 Mar 2024 14:35:11 +0000 https://biotherapypartners.com/?p=1850 Read more]]> Biotherapy Partners will attend SFTCG 2024

Olivier Negre, co-founder of Biotherapy Partners, will attend SFTCG’s workshop (link).

To schedule a meeting, contact us at info@biotherapypartners.com.

Biotherapy Partners is a consulting firm providing support for the drug development of Biologicals like mAbs or gene and cell therapies

]]> https://biotherapypartners.com/biotherapy-partners-will-attend-sftcg-worshop-gene-editing-and-cell-therapy/feed/ 0 ATMP development: Key Pathway Resources published by EuroGCT https://biotherapypartners.com/atmp-development-key-pathway-resources-published-by-eurogct/ https://biotherapypartners.com/atmp-development-key-pathway-resources-published-by-eurogct/#respond Tue, 12 Mar 2024 14:29:40 +0000 https://biotherapypartners.com/?p=1844 Read more]]> Key resources on ATMP development by medicines agencies accessible online

Key Pathway Resources | EuroGCT

Biotherapy Partners is serving international biotechs, VCs & TTOs to address their scientific, technical & operating challenges in drug development, i.e. Non-Clinical/Translation, CMC/AD, Clinical, Bioanalysis, Lab operations, Regulatory and QA & Project Management. Biotherapy Partners is tackling specifically the challenges of Biologicals, including mAb/ADC, gene and cell therapies.

Our purpose is to translate research ideas into therapies, for the benefit of patients.

]]> https://biotherapypartners.com/atmp-development-key-pathway-resources-published-by-eurogct/feed/ 0 Innovations for cell & gene therapies conference 2024 https://biotherapypartners.com/innovations-for-cell-gene-therapies-conference-2024/ https://biotherapypartners.com/innovations-for-cell-gene-therapies-conference-2024/#respond Mon, 11 Mar 2024 09:47:31 +0000 https://biotherapypartners.com/?p=1838 Read more]]> Biotherapy Partners is attending ICGT 2024 in Paris

During a full day (program), meet the experts from academia, clinical and industry in Cell and Gene Therapies.

With scientific talks given by high level speakers, an exhibition hall allowing companies to showcase their last innovations and B2B meetings to connect and create partnership.

Meet our Experts at the conference: Alexis COLLETTE, President & cofounder, and Olivier NEGRE, Partner & cofounder.

To schedule a meeting, contact us at info@biotherapypartners.com.

Biotherapy Partners is a consulting firm providing support for the development of Advanced Therapy Medicinal Products, especially gene and cell therapies

]]> https://biotherapypartners.com/innovations-for-cell-gene-therapies-conference-2024/feed/ 0 France Bioproduction Congress 2024 https://biotherapypartners.com/france-bioproduction-congress-2024/ https://biotherapypartners.com/france-bioproduction-congress-2024/#respond Mon, 11 Mar 2024 09:02:19 +0000 https://biotherapypartners.com/?p=1833 Read more]]> Biotherapy Partners will attend France Bioproduction Congress 2024 at Saclay, France

Alexis COLLETTE, co-founder and President of Biotherapy Partners, will attend France BioProduction Congress 2024, where French drug manufacturing is discussed.

To schedule a meeting, contact us at info@biotherapypartners.com.

Biotherapy Partners is a consulting firm providing support for the development of Advanced Therapy Medicinal Products, especially gene and cell therapies

]]> https://biotherapypartners.com/france-bioproduction-congress-2024/feed/ 0 Biotherapy Partners is attending BioSpring Europe 2024 in Barcelona https://biotherapypartners.com/biotherapy-partners-is-attending-biospring-europe-2024-in-barcelona/ https://biotherapypartners.com/biotherapy-partners-is-attending-biospring-europe-2024-in-barcelona/#respond Tue, 20 Feb 2024 18:18:17 +0000 https://biotherapypartners.com/?p=1803 Read more]]> Biotherapy Partners is attending BioSpring Europe 2024 conference in Barcelona, Spain

Alexis COLLETTE, CEO & co-founder of Biotherapy Partners is attending Biospring Europe 2024 in Barcelona, Spain, from March 18th to 20th, 2024 to meet clients, partners and providers for biotherapy product development.

To schedule a meeting, contact us at info@biotherapypartners.com.

Biotherapy Partners is a consulting firm providing support for the development of Advanced Therapy Medicinal Products, especially gene and cell therapies

]]> https://biotherapypartners.com/biotherapy-partners-is-attending-biospring-europe-2024-in-barcelona/feed/ 0 Biotherapy Partners attended Biofit 2023 https://biotherapypartners.com/biotherapy-partners-attended-biofit-2023/ https://biotherapypartners.com/biotherapy-partners-attended-biofit-2023/#respond Wed, 31 Jan 2024 16:54:24 +0000 https://biotherapypartners.com/?p=1761 Read more]]>

Biotherapy Partners attended the Biofit 2023 conference in Marseille, France

Alexis COLLETTE, CEO & co-founder of Biotherapy Partners attended Biofit 2023 in Marseille France, from December 12th to 13th, 2023 to meet clients, partners and providers for biotherapy product development.

]]> https://biotherapypartners.com/biotherapy-partners-attended-biofit-2023/feed/ 0 Wrap up of 2023 for Biotherapy Partners https://biotherapypartners.com/wrap-up-of-2023-for-biotherapy-partners/ https://biotherapypartners.com/wrap-up-of-2023-for-biotherapy-partners/#respond Tue, 30 Jan 2024 17:32:30 +0000 https://biotherapypartners.com/?p=1782 Read more]]>

Wrap up of 2023 for Biotherapy Partners

January is a good time to reflect on the past year for Biotherapy Partners.
In 2023, we contributed to 19 projects for 11 companies to help them advance their Biological Drug Development programs.
These projects encompassed: Biologicals, genetherapy, celltherapy, for strategic and/or operational drug development, due diligence or trainings.
Biotherapy Partners contributed to 1 CTA filing for a new CAR T program and 1 IMPD for a biological.
We also launched our website!  Please visit Home – Biotherapy Partners
We look forward to continuing developing Drugs in 2024 through our consulting activities! Do not hesitate to contact us at contact@biotherapypartners.com

]]> https://biotherapypartners.com/wrap-up-of-2023-for-biotherapy-partners/feed/ 0 Biotherapy Partners will attend ESGCT 2023 https://biotherapypartners.com/biotherapy-partners-will-attend-esgct-2023/ https://biotherapypartners.com/biotherapy-partners-will-attend-esgct-2023/#respond Thu, 26 Oct 2023 09:45:35 +0000 https://biotherapy-preprod.bncsys.eu/?p=1734 Read more]]> Biotherapy Partners will attend the conference of the European Society of Gene and Cell Therapy in Brussels, Belgium

Olivier Negre, co-founder of Biotherapy Partners and Chief Scientific Officer of Smart Immune will give a presentation on CAR ProTcell platform developed by Smart Immune: CAR ProTcell, towards well-tolerated and persistent off-the-shelf allogeneic CAR-T cells.

To schedule a meeting, contact us at info@biotherapypartners.com.

Biotherapy Partners is a consulting firm providing support for the development of Advanced Therapy Medicinal Products, especially gene and cell therapies

]]> https://biotherapypartners.com/biotherapy-partners-will-attend-esgct-2023/feed/ 0 Biotherapy Partners will attend ATE 2023 https://biotherapypartners.com/biotherapy-partners-will-attend-ate-2023/ https://biotherapypartners.com/biotherapy-partners-will-attend-ate-2023/#respond Thu, 26 Oct 2023 09:35:18 +0000 https://biotherapy-preprod.bncsys.eu/?p=1731 Read more]]>
Biotherapy Partners will attend the conference Advance Therapy Europe in Estoril, Portugal
Olivier Negre, co-founder of Biotherapy Partners and Chief Scientific Officer of Smart Immune
will give a presentation on the ProTcell platform developed by Smart Immune: Development of allogeneic CAR-T cells based on T cell progenitors

To schedule a meeting, contact us at info@biotherapypartners.com.

Biotherapy Partners is a consulting firm providing support for the development of Advanced Therapy Medicinal Products, especially gene and cell therapies

]]> https://biotherapypartners.com/biotherapy-partners-will-attend-ate-2023/feed/ 0 Biotherapy Partners will attend ITD 2023 https://biotherapypartners.com/biotherapy-partners-attended-itd-2023-in-besancon-france/ https://biotherapypartners.com/biotherapy-partners-attended-itd-2023-in-besancon-france/#respond Tue, 03 Oct 2023 15:35:10 +0000 https://biotherapy-preprod.bncsys.eu/?p=1707 Read more]]>

Biotherapy Partners will attend the conference Innovative Therapies Days 2023 in Besancon, France

Olivier Negre, co-founder of Biotherapy Partners and Chief Scientific Officer of Smart Immune will give a presentation on CAR ProTcell platform developed by Smart Immune: Designing next generation allogeneic T-cell therapies empowered by the thymus

To schedule a meeting, contact us at info@biotherapypartners.com.

Biotherapy Partners is a consulting firm providing support for the development of Advanced Therapy Medicinal Products, especially gene and cell therapies

]]> https://biotherapypartners.com/biotherapy-partners-attended-itd-2023-in-besancon-france/feed/ 0